Our Research Publications
Updated August 2024
Pagination
- Previous page
- Page 25
- Next page
Title | Authors | Year Sort ascending | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Protocol for a phase III, non-inferiority, randomised comparison of a new fibrinogen concentrate versus cryoprecipitate for treating acquired hypofibrinogenaemia in bleeding cardiac surgical patients: the FIBRES trial | Karkouti K, Callum J, Rao V, Heddle N, Farkouh ME, Crowther MA, Scales DC | 2018 | BMJ Open | View Protocol for a phase III, non-inferiority, randomised comparison of a new fibrinogen concentrate versus cryoprecipitate for treating acquired hypofibrinogenaemia in bleeding cardiac surgical patients: the FIBRES trial | Researchers | Clinical research |
Investigations for fetal and neonatal alloimmune thrombocytopenia: communication from the SSC of the ISTH | Petermann R, Bakchoul T, Curtis BR, Mullier F, Miyata S, Arnold DM, Subcommittee on platelet immunology | 2018 | J Thromb Haemost | View Investigations for fetal and neonatal alloimmune thrombocytopenia: communication from the SSC of the ISTH | Health care providers | Benchmarking and standard setting |
Transfusion de plaquettes, l'allo-immunisation et la prise en charge de l'état réfractaire aux plaquettes | Zeller M, Petraszko T | 2018 | Guide de la pratique transfusionnelle | View Transfusion de plaquettes, l'allo-immunisation et la prise en charge de l'état réfractaire aux plaquettes | Health care providers | Other |
ResearchUnit: Improving the usefulness of a laboratory tool to match donors and patients | Acker J, Branch D | 2018 | Blood.ca website | View ResearchUnit: Improving the usefulness of a laboratory tool to match donors and patients | Other | Other |
Chloride and other electrolyte concentrations in commonly available 5% albumin products | Lai AT, Zeller MP, Millen T, Kavsak P, Szczeklik W, Elahie A, Alhazzani W, D'Aragon F, Jaeschke R, Lamontagne F, Karachi T, Cook D, Meade M, Rochwerg B, on behalf of The Canadian Critical Care Trials Group | 2018 | Crit Care Med | View Chloride and other electrolyte concentrations in commonly available 5% albumin products | Health care providers | Clinical research |
Rapport de surveillance 2017 | O'Brien S | 2018 | Blood.ca website | View Rapport de surveillance 2017 | Other | Other |
Red blood cells, still vital after all these years: Commentary on Canadian Blood Services' International Symposium 2017 | Qadri SM, Donkor DA, Yan M, Ning S, Branch DR, Seghatchian J, Sheffield WP | 2018 | Transfus Apher Sci | View Red blood cells, still vital after all these years: Commentary on Canadian Blood Services' International Symposium 2017 | Researchers | Other |
Megakaryocyte apoptosis in immune thrombocytopenia | Vrbensky JR, Nazy I, Toltl LJ, Ross C, Ivetic N, Smith JW, Kelton JG, Arnold DM | 2018 | Platelets | View Megakaryocyte apoptosis in immune thrombocytopenia | Researchers | Basic research |
Autoantibodies to thrombopoietin and the thrombopoietin receptor in patients with immune thrombocytopenia | Nazy I, Kelton JG, Moore JC, Clare R, Horsewood P, Smith JW, Ivetic N, D'Souza V, Li N, Arnold DM | 2018 | Br J Haematol | View Autoantibodies to thrombopoietin and the thrombopoietin receptor in patients with immune thrombocytopenia | Health care providers | Clinical research |
Blood and clots series: Which antithrombotic therapy should I start for my patient with acute VTE? | Tseng E | 2018 | CanadiEM website | View Blood and clots series: Which antithrombotic therapy should I start for my patient with acute VTE? | Health care providers | Benchmarking and standard setting |
Impact of organizational interventions on reducing inappropriate intravenous immunoglobulin (IVIG) usage: A systematic review and meta-analysis | Diep C, Shih AW, Jamula E, Heddle NM, Parvizian M, Hillis CM | 2018 | Transfus Apher Sci | View Impact of organizational interventions on reducing inappropriate intravenous immunoglobulin (IVIG) usage: A systematic review and meta-analysis | Health care providers | Clinical research |
ResearchUnit: Developing more inclusive deferral policies for blood and plasma donors | Goldman M, O'Brien S, Devine D | 2018 | Blood.ca website | View ResearchUnit: Developing more inclusive deferral policies for blood and plasma donors | Other | Other |
Feasibility of the use of a handheld XRF analyzer to measure skin iron to monitor iron levels in critical organs | Dao E, Zeller MP, Wainman BC, Farquharson MJ | 2018 | J Trace Elem Med Biol | View Feasibility of the use of a handheld XRF analyzer to measure skin iron to monitor iron levels in critical organs | Health care providers | New or improved product or process |
What Goes Up, Must Go Down? | Parker MJ | 2018 | Pediatr Crit Care Med | View What Goes Up, Must Go Down? | Researchers | Clinical research |
Extending the pre-processing holding time of whole blood beyond 48h reduces coagulation FVIII activity and immunoglobulin G content of recovered plasma | Sheffield WP, Bhakta V, Jenkins C | 2018 | Transfus Apher Sci | View Extending the pre-processing holding time of whole blood beyond 48h reduces coagulation FVIII activity and immunoglobulin G content of recovered plasma | Researchers | New or improved product or process |
High sensitivity and specificity of an automated IgG-specific chemiluminescence immunoassay for diagnosis of HIT | Warkentin TE, Sheppard JI, Linkins L, Arnold DM, Nazy I | 2018 | Blood | View High sensitivity and specificity of an automated IgG-specific chemiluminescence immunoassay for diagnosis of HIT | Researchers | New or improved product or process |
Anti-D; a type of IVIg | Khan R, Lazarus A | 2018 | Antibody Therapy: Substitution - Immunomodulation - Monoclonal Immunotherapy | View Anti-D; a type of IVIg | Health care providers | Other |
Fc-independent immune thrombocytopenia via mechanomolecular signaling in platelets | Quach ME, Dragovich MA, Chen W, Syed AK, Cao W, Liang X, Deng W, De Meyer SF, Zhu G, Peng J, Ni H, Bennett CM, Hou M, Ware J, Deckmyn H, Zhang XF, Li R | 2018 | Blood | View Fc-independent immune thrombocytopenia via mechanomolecular signaling in platelets | Researchers | Basic research |
Improved resolution in extracellular vesicle populations using 405 instead of 488Â nm side scatter | McVey MJ, Spring CM, Kuebler WM | 2018 | J Extracell Vesicles | View Improved resolution in extracellular vesicle populations using 405 instead of 488Â nm side scatter | Researchers | Basic research |
Cardiac stress biomarkers after red blood cell transfusion in patients at risk for transfusion-associated circulatory overload: a prospective observational study | Callum JL, Cohen R, Cressman AM, Strauss R, Armali C, Lin Y, Pendergrast J, Lieberman L, Scales DC, Skeate R, Ross H, Cserti-Gazdewich C | 2018 | Transfusion | View Cardiac stress biomarkers after red blood cell transfusion in patients at risk for transfusion-associated circulatory overload: a prospective observational study | Researchers | Clinical research |
Moving from a permanent to a 5 year deferral for donors with cured cancer results in a substantial reduction in deferral rates | Goldman M, Yi Q-L, O'Brien SF | 2018 | ISBT Sci Ser | View Moving from a permanent to a 5 year deferral for donors with cured cancer results in a substantial reduction in deferral rates | Blood operators | New or improved product or process |
Electronic patient identification for sample labeling reduces wrong blood in tube errors | Kaufman RM, Dinh A, Cohn CS, Fung MK, Gorlin J, Melanson S, Murphy MF, Ziman A, Elahie AL, Chasse D, Degree L, Dunbar NM, Dzik WH, Flanagan P, Gabert K, Ipe TS, Jackson B, Lane D, Raspollini E, Ray C, Sharon Y, Ellis M, Selleng K, Staves J, Yu P, Zeller M, Yazer M, BEST Collaborative | 2018 | Transfusion | View Electronic patient identification for sample labeling reduces wrong blood in tube errors | Researchers | Clinical research |
Sample collection and sample handling errors submitted to the transfusion error surveillance system, 2006 to 2015 | Strauss R, Downie H, Wilson A, Mounchili A, Berry B, Cserti-Gazdewich C, Callum J | 2018 | Transfusion | View Sample collection and sample handling errors submitted to the transfusion error surveillance system, 2006 to 2015 | Health care providers | Clinical research |
Platelet transfusion, alloimmunization, and management of platelet refractoriness | Zeller M, Petraszko T | 2018 | Clinical Guide to Transfusion | View Platelet transfusion, alloimmunization, and management of platelet refractoriness | Health care providers | Other |
Targeted recruitment of male donors for allogeneic haematopoietic cell transplantation: A review of the evidence | Fingrut W, Rikhraj K, Allan D | 2018 | Vox Sang | View Targeted recruitment of male donors for allogeneic haematopoietic cell transplantation: A review of the evidence | Blood operators | Clinical research |
Concentré de recherche: Où l'on optimise un test de laboratoire pour déterminer la compatibilité entre donneurs et receveurs | Acker J, Branch D | 2018 | Blood.ca website | View Concentré de recherche: Où l'on optimise un test de laboratoire pour déterminer la compatibilité entre donneurs et receveurs | Other | Other |
Anti-M | Clarke G, Cote J, Lane D | 2018 | Blood.ca website | View Anti-M | Researchers | Basic research |
International validation of harmonized definitions for complications of blood donations | Land KJ, Townsend M, Goldman M, Whitaker BI, Perez GE, Wiersum-Osselton JC | 2018 | Transfusion | View International validation of harmonized definitions for complications of blood donations | Blood operators | New or improved product or process |
Role of von Willebrand factor and ADAMTS-13 in early brain injury after experimental subarachnoid hemorrhage | Wan H, Wang Y, Ai J, Brathwaite S, Ni H, Macdonald RL, Hol EM, Meijers JCM, Vergouwen MDI | 2018 | J Thromb Haemost | View Role of von Willebrand factor and ADAMTS-13 in early brain injury after experimental subarachnoid hemorrhage | Researchers | Basic research |
Erythrocyte saturation with IgG is required for inducing antibody-mediated immune suppression and impacts both erythrocyte clearance and antigen-modulation mechanisms | Cruz-Leal Y, Marjoram D, Lazarus AH | 2018 | J Immunol | View Erythrocyte saturation with IgG is required for inducing antibody-mediated immune suppression and impacts both erythrocyte clearance and antigen-modulation mechanisms | Researchers | Basic research |
Fusion to human serum albumin extends the circulatory half-life and duration of antithrombotic action of the Kunitz protease inhibitor domain of Protease Nexin 2 | Sheffield WP, Eltringham-Smith LJ, Bhakta V | 2018 | Cell Physiol Biochem | View Fusion to human serum albumin extends the circulatory half-life and duration of antithrombotic action of the Kunitz protease inhibitor domain of Protease Nexin 2 | Researchers | Basic research |
Modeling rare blood in Canada | Blake JT, Clarke G | 2018 | Transfusion | View Modeling rare blood in Canada | Health care providers | New or improved product or process |
Serpin Phage Display: The Use of a T7 System to Probe Reactive Center Loop Libraries with Different Serine Proteinases | de Souza LR, Scott BM, Bhakta V, Donkor DA, Perruzza DL, Sheffield WP | 2018 | Serpins: Methods and Protocols | View Serpin Phage Display: The Use of a T7 System to Probe Reactive Center Loop Libraries with Different Serine Proteinases | Researchers | Other |
Circular of information for the use of human blood components: Red blood cells, Leukocytes Reduced (LR) | Jenkins C | 2018 | Blood.ca website | View Circular of information for the use of human blood components: Red blood cells, Leukocytes Reduced (LR) | Health care providers | Benchmarking and standard setting |
Systematic review of fondaparinux for heparin-induced thrombocytopenia: When there are no randomized controlled trials | Linkins L, Hu G, Warkentin TE | 2018 | Res Pract Thromb Haemost | View Systematic review of fondaparinux for heparin-induced thrombocytopenia: When there are no randomized controlled trials | Researchers | Clinical research |
A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss | Sheffield WP, Eltringham-Smith LJ, Bhakta V | 2018 | BMC Biotechnol | View A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss | Researchers | Basic research |
Chloride and other electrolyte concentrations in commonly available 5% albumin products | Lai AT, Zeller MP, Millen T, Kavsak P, Szczeklik W, Elahie A, Alhazzani W, D'Aragon F, Jaeschke R, Lamontagne F, Karachi T, Cook D, Meade M, Rochwerg B | 2018 | Crit Care Med | View Chloride and other electrolyte concentrations in commonly available 5% albumin products | Researchers | Clinical research |
Rivaroxaban and Apixaban induce clotting factor Xa fibrinolytic activity | Carter RLR, Talbot K, Hur WS, Meixner SC, Van Der Gugten JG, Holmes DT, Côté HCF, Kastrup CJ, Smith TW, Lee AYY, Pryzdial ELG | 2018 | J Thromb Haemost | View Rivaroxaban and Apixaban induce clotting factor Xa fibrinolytic activity | Health care providers | Basic research |
The potential role of a turbidimetric heart-type fatty acid-binding protein assay to aid in the interpretation of persistently elevated, non-changing, cardiac troponin I concentrations | Kavsak PA, Ainsworth C, Arnold DM, Scott T, Clark L, Ivica J, Mackett K, Whitlock R, Worster A | 2018 | Clin Biochem | View The potential role of a turbidimetric heart-type fatty acid-binding protein assay to aid in the interpretation of persistently elevated, non-changing, cardiac troponin I concentrations | Researchers | Basic research |
Synthesis of Highly Biocompatible and Temperature-Responsive Physical Gels for Cryopreservation and 3D Cell Culture | Nagao M, Sengupta J, Diaz-Dussan D, Adam M, Wu M, Acker J, Ben R, Ishihara K, Zeng H, Miura Y, Narain R | 2018 | ACS Appl Bio Mater | View Synthesis of Highly Biocompatible and Temperature-Responsive Physical Gels for Cryopreservation and 3D Cell Culture | Researchers | Basic research |
A multicentred study to validate a consensus bleeding assessment tool developed by the biomedical excellence for safer transfusion collaborative for use in patients with haematological malignancy | Dyer C, Alquist CR, Cole-Sinclair M, Curnow E, Dunbar NM, Estcourt LJ, Kaufman R, Kutner JM, McCullough J, McQuilten Z, Potiphar L, Rioux-Masse B, Slichter S, Tinmouth A, Webert K, Yokoyama AP, Stanworth SJ | 2018 | Vox Sang | View A multicentred study to validate a consensus bleeding assessment tool developed by the biomedical excellence for safer transfusion collaborative for use in patients with haematological malignancy | Health care providers | Clinical research |
Questioning some recommendations in the umbilical cord blood guideline | Elmoazzen H, Petraszko T | 2018 | J Obstet Gynaecol Can | View Questioning some recommendations in the umbilical cord blood guideline | Health care providers | New or improved product or process |
ResearchUnit: A model for change: predicting the impact of system-wide improvements | Blake J | 2018 | Blood.ca website | View ResearchUnit: A model for change: predicting the impact of system-wide improvements | Other | New or improved product or process |
Screening of red blood cells for extracellular vesicle content as a product quality indicator | Acker JP, Almizraq RJ, Millar D, Maurer-Spurej E | 2018 | Transfusion | View Screening of red blood cells for extracellular vesicle content as a product quality indicator | Researchers | New or improved product or process |
Anti-M (French) | Clarke G, Cote J, Lane D | 2018 | Blood.ca website | View Anti-M (French) | Researchers | Basic research |
Cyclic thrombocytopenia with statistically significant neutrophil oscillations | Langlois GP, Arnold DM, Potts J, Leber B, Dale DC, Mackey MC | 2018 | Clin Case Rep | View Cyclic thrombocytopenia with statistically significant neutrophil oscillations | Health care providers | Clinical research |
Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation | Qu M, Liu Q, Zhao H-G, Peng J, Ni H, Hou M, Jansen AJG | 2018 | Ann Hematol | View Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation | Health care providers | Clinical research |
Changes in plasma unit distributions to hospitals over a 10-year period | Seheult JN, Shaz B, Bravo M, Croxon H, Devine D, Doncaster C, Field S, Flanagan P, Germain M, Gregoire Y, Kamel H, Karafin M, Kelting N, Lewis M, O'Brien C, Murphy MF, Rossmann S, Sayers M, Shinar E, Takanashi M, Titlestad K, Yazer MH | 2018 | Transfusion | View Changes in plasma unit distributions to hospitals over a 10-year period | Blood operators | Clinical research |
ResearchUnit: Patient blood group impacts susceptibility to IVIg-associated hemolysis | Branch D | 2018 | Blood.ca website | View ResearchUnit: Patient blood group impacts susceptibility to IVIg-associated hemolysis | Researchers | Basic research |
A Deep Learning Method to Automatically Identify Reports of Scientifically Rigorous Clinical Research from the Biomedical Literature: Comparative Analytic Study | Del Fiol G MM, Iorio A, Cotoi C, Haynes RB | 2018 | J Med Internet Res | View A Deep Learning Method to Automatically Identify Reports of Scientifically Rigorous Clinical Research from the Biomedical Literature: Comparative Analytic Study | Researchers | Clinical research |